Back to Search
SURASAK PHUPHANICH, M.D.
M.D.
Neurology Physician
NPI: 1457469074Individual
Specialties, Licenses & Credentials
Medical Oncology Physician
Internal Medicine — Medical Oncology
Code: 207RX0202X
53514(GA)
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
53135(AZ)A36229(CA)
Research & Publications (20)
Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant glioma.
PMID 18477765·Neuro Oncol·2008
5-case
A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study.
PMID 16941075·J Neurooncol·2007
3-trial
Neurologic improvement after high-dose intravenous immunoglobulin therapy in patients with paraneoplastic cerebellar degeneration associated with anti-Purkinje cell antibody.
PMID 16773214·J Neurooncol·2007
5-case
Oral sodium phenylbutyrate in patients with recurrent malignant gliomas: a dose escalation and pharmacologic study.
PMID 15831235·Neuro Oncol·2005
3-trial
Delivery systems and molecular targets of mechanism-based therapies for GBM.
PMID 15853584·Expert Rev Neurother·2004
6-review
DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas.
PMID 19432816·J Cell Mol Med·2010
8-other
Phase I analysis of BCNU-impregnated biodegradable polymer wafers followed by systemic interferon alfa-2b in adults with recurrent glioblastoma multiforme.
PMID 18679580·J Neurooncol·2008
3-trial
Phase I and pharmacokinetic study of karenitecin in patients with recurrent malignant gliomas.
PMID 18577560·Neuro Oncol·2008
3-trial
Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells.
PMID 17638906·Cancer Res·2007
8-other
Treatment related myelitis in Hodgkin's lymphoma following stem cell transplant, chemotherapy and radiation: a case report and review of the literature.
PMID 16617406·J Neurooncol·2006
5-case
The effect of enzyme-inducing antiseizure drugs on the pharmacokinetics and tolerability of procarbazine hydrochloride.
PMID 16951236·Clin Cancer Res·2006
3-trial
Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation.
PMID 16636750·J Neurooncol·2006
4-observational
Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma.
PMID 16053699·Neuro Oncol·2005
3-trial
Treatment of neoplastic meningitis: what is the standard of care?
PMID 15853550·Expert Rev Neurother·2004
6-review
A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting.
PMID 15509513·Mol Ther·2004
3-trial
Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: final report of NABTT 97-11.
PMID 14769136·Neuro Oncol·2004
3-trial
A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma.
PMID 12672281·Neuro Oncol·2003
3-trial
Recurrent multicentric glioblastoma multiforme responds to thalidomide and chemotherapy.
PMID 15046387·Oncology (Williston Park)·2002
5-case
Complete response of a recurrent, multicentric malignant glioma in a patient treated with phenylbutyrate.
PMID 12241121·J Neurooncol·2002
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 127 South San Vicente BLVD, Suite A6600, Cedars-Sinai Medical Center-AHSP
Los Angeles, CA 90048 - Phone
- (310) 423-8100
Quick Facts
- NPI
- 1457469074
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 3
- Publications
- 20
Are you this provider?
Claim Your Profile